{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:01:49Z","timestamp":1762628509493,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2023.100784","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T21:50:00Z","timestamp":1703022600000},"page":"100784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The symptom burden of women with a known risk of breast cancer receiving risk reducing medication"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9791-1227","authenticated-orcid":false,"given":"Meagan S.","family":"Whisenant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Trevi\u00f1o","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneliese O.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese Bartholomew","family":"Bevers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Brassil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darcy A.","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharvari","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Solis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Maliackal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Warlick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Denham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretta A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2022","series-title":"Breast Cancer Facts & Figures 2022-2024","key":"10.1016\/j.ctarc.2023.100784_bib0001"},{"issue":"5","key":"10.1016\/j.ctarc.2023.100784_bib0002","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00002820-200509000-00008","article-title":"Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities","volume":"28","author":"Boehmke","year":"2005","journal-title":"Cancer Nurs."},{"issue":"2","key":"10.1016\/j.ctarc.2023.100784_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejon.2009.09.005","article-title":"The effect of symptom clusters on functional status and quality of life in women with breast cancer","volume":"14","author":"Dodd","year":"2010","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"1","key":"10.1016\/j.ctarc.2023.100784_bib0004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.gco.0000192996.20040.24","article-title":"Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients","volume":"18","author":"Kayl","year":"2006","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ctarc.2023.100784_bib0005","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1188\/06.ONF.775-783","article-title":"Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study","volume":"33","author":"Payne","year":"2006","journal-title":"Oncol. Nurs. Forum"},{"issue":"6","key":"10.1016\/j.ctarc.2023.100784_bib0006","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology Breast Cancer survivorship care guideline","volume":"34","author":"Runowicz","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2023.100784_bib0007","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1245\/s10434-015-4715-9","article-title":"Chemoprevention for breast cancer","volume":"22","author":"Pruthi","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2023.100784_bib0008","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1586\/14737167.2016.1159514","article-title":"Endocrine therapy for breast cancer prevention in high-risk women: clinical and economic considerations","volume":"16","author":"Groom","year":"2016","journal-title":"Expert. Rev. Pharmacoecon. Outcome. Res"},{"issue":"23","key":"10.1016\/j.ctarc.2023.100784_bib0009","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","article-title":"Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Visvanathan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2023.100784_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105834","article-title":"Breast cancer chemoprevention: An update on current practice and opportunities for primary care physicians","volume":"129","author":"Ball","year":"2019","journal-title":"Prev. Med."},{"issue":"9880","key":"10.1016\/j.ctarc.2023.100784_bib0011","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","author":"Cuzick","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ctarc.2023.100784_bib0012","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/annonc\/mdv590","article-title":"Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis","volume":"27","author":"Smith","year":"2016","journal-title":"Ann. Oncol."},{"issue":"18","key":"10.1016\/j.ctarc.2023.100784_bib0013","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"10218","key":"10.1016\/j.ctarc.2023.100784_bib0014","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(19)32955-1","article-title":"Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial","volume":"395","author":"Cuzick","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ctarc.2023.100784_bib0015","first-page":"186","article-title":"Priorities for the primary prevention of breast cancer","volume":"64","author":"Colditz","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ctarc.2023.100784_bib0016","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.14694\/EdBook_AM.2015.35.e50","article-title":"Addressing barriers to uptake of breast cancer chemoprevention for patients and providers","author":"Crew","year":"2015","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"7","key":"10.1016\/j.ctarc.2023.100784_bib0017","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jnci\/95.7.526","article-title":"Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention","volume":"95","author":"Freedman","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.ctarc.2023.100784_bib0018","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jama.2019.11885","article-title":"Medication use to reduce risk of breast cancer: US preventive services task force recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ctarc.2023.100784_bib0019","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/jama.2019.5780","article-title":"Medication use for the risk reduction of primary breast cancer in women: updated evidence report and systematic review for the US preventive services task force","volume":"322","author":"Nelson","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ctarc.2023.100784_bib0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.2019.9689","article-title":"Medications to reduce breast cancer risk: promise and limitations","volume":"322","author":"Pace","year":"2019","journal-title":"JAMA"},{"issue":"9922","key":"10.1016\/j.ctarc.2023.100784_bib0021","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ctarc.2023.100784_bib0022","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","article-title":"Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis","volume":"28","author":"Ropka","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2023.100784_bib0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.breast.2014.11.006","article-title":"Acceptance and adherence to chemoprevention among women at increased risk of breast cancer","volume":"24","author":"Roetzheim","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.ctarc.2023.100784_bib0024","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.14694\/EdBook_AM.2015.35.e59","article-title":"Decision making in the context of breast cancer chemoprevention: patient perceptions and the meaning of risk","author":"Holmberg","year":"2015","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.ctarc.2023.100784_bib0025","first-page":"1","article-title":"Layers of information: interacting constraints on breast cancer risk-management by high-risk African American women","author":"Padamsee","year":"2018","journal-title":"Eth. Health"},{"issue":"6","key":"10.1016\/j.ctarc.2023.100784_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.03.031","article-title":"Use of raloxifene and tamoxifen by breast cancer risk level in a Medicare-eligible cohort","volume":"218","author":"Pinsky","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ctarc.2023.100784_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012550","article-title":"Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study","volume":"6","author":"Khaliq","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ctarc.2023.100784_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/CEJ.0000000000000124","article-title":"Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer","volume":"25","author":"Aktas","year":"2016","journal-title":"Eur. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.ctarc.2023.100784_bib0029","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1055-9965.EPI-09-0930","article-title":"Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women","volume":"19","author":"Waters","year":"2010","journal-title":"Cancer Epidemiol. Biomark Prev."},{"key":"10.1016\/j.ctarc.2023.100784_bib0030","unstructured":"Warner E., Messersmith H., Causer P., Eisen A., Shumak R., Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann. Intern. Med. PMID: 18458280."},{"issue":"1","key":"10.1016\/j.ctarc.2023.100784_bib0031","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.ede.0000251167.75581.98","article-title":"Physical activity and breast cancer: a systematic review","volume":"18","author":"Monninkhof","year":"2007","journal-title":"Epidemiol."},{"issue":"7","key":"10.1016\/j.ctarc.2023.100784_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/nu11071514","article-title":"Nutrition and breast cancer: a literature review on prevention, treatment and recurrence","volume":"11","author":"De Cicco","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ctarc.2023.100784_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4845059","article-title":"Long-term sleep duration as a risk factor for breast cancer: evidence from a systematic review and dose-response meta-analysis","volume":"2017","author":"Lu","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.ctarc.2023.100784_bib0034","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13058-017-0826-5","article-title":"Decision making for breast cancer prevention among women at elevated risk","volume":"19","author":"Padamsee","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.ctarc.2023.100784_bib0035","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1245\/s10434-019-07236-8","article-title":"Chemoprevention uptake for breast cancer risk reduction varies by risk factor","volume":"26","author":"Flanagan","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2023.100784_bib0036","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1158\/1940-6207.CAPR-17-0100","article-title":"Chemoprevention uptake among women with atypical hyperplasia and lobular and ductal carcinoma in situ","volume":"10","author":"Trivedi","year":"2017","journal-title":"Cancer Prev. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2023.100784_bib0037","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-012-1960-5","article-title":"Willingness to use tamoxifen to prevent breast cancer among diverse women","volume":"133","author":"Kaplan","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.ctarc.2023.100784_bib0038","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10549-017-4332-3","article-title":"Preferences for breast cancer risk reduction among BRCA1\/BRCA2 mutation carriers: a discrete-choice experiment","volume":"165","author":"Liede","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.ctarc.2023.100784_bib0039","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1200\/JCO.2016.68.8895","article-title":"Factors associated with early discontinuation of study treatment in the mammary prevention.3 breast cancer chemoprevention trial","volume":"35","author":"Meggetto","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2023.100784_bib0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1037\/a0013608","article-title":"Explanations for side effect aversion in preventive medical treatment decisions","volume":"28","author":"Waters","year":"2009","journal-title":"Health Psychol."},{"issue":"3","key":"10.1016\/j.ctarc.2023.100784_bib0041","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1370\/afm.284","article-title":"Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump","volume":"3","author":"Taylor","year":"2005","journal-title":"Ann. Fam. Med."},{"issue":"5","key":"10.1016\/j.ctarc.2023.100784_bib0042","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1097\/NCC.0000000000000632","article-title":"Symptom map of endocrine therapy for breast cancer: a scoping review","volume":"42","author":"Zhu","year":"2019","journal-title":"Cancer Nurs."},{"issue":"10","key":"10.1016\/j.ctarc.2023.100784_bib0043","first-page":"471","article-title":"Supportive care of women with breast cancer: key concerns and practical solutions","volume":"205","author":"Zdenkowski","year":"2016","journal-title":"Med. J. Aist."},{"issue":"3","key":"10.1016\/j.ctarc.2023.100784_bib0044","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10549-007-9682-9","article-title":"Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women","volume":"109","author":"Cella","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"23","key":"10.1016\/j.ctarc.2023.100784_bib0045","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1001\/jama.295.23.joc60075","article-title":"Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Land","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ctarc.2023.100784_bib0046","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/NCC.0b013e318269040f","article-title":"Comparison between patient-reported and clinician-observed symptoms in oncology","volume":"36","author":"Xiao","year":"2013","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.ctarc.2023.100784_bib0047","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1200\/EDBK_175418","article-title":"Improving cancer care through the patient experience: how to use patient-reported outcomes in clinical practice","volume":"37","author":"Mooney","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Ed. Book"},{"issue":"37","key":"10.1016\/j.ctarc.2023.100784_bib0048","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/jncimonographs\/lgm005","article-title":"Symptom burden: multiple symptoms and their impact as patient-reported outcomes","author":"Cleeland","year":"2007","journal-title":"J. Natl. Cancer Inst. Monogr."},{"issue":"9 Suppl 10","key":"10.1016\/j.ctarc.2023.100784_bib0049","first-page":"64","article-title":"When is it justified to treat symptoms? Measuring symptom burden","volume":"16","author":"Cleeland","year":"2002","journal-title":"Oncology (Williston Park)"},{"issue":"3","key":"10.1016\/j.ctarc.2023.100784_bib0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/srao.2000.6590","article-title":"Cancer-related symptoms","volume":"10","author":"Cleeland","year":"2000","journal-title":"Semin. Radiat. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2023.100784_bib0051","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1200\/JCO.2010.30.3909","article-title":"Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial","volume":"29","author":"Berry","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2023.100784_bib0052","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2023.100784_bib0053","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1188\/17.ONF.739-750","article-title":"Distinct trajectories of fatigue and sleep disturbance in women receiving chemotherapy for breast cancer","volume":"44","author":"Whisenant","year":"2017","journal-title":"Oncol. Nurs. Forum"},{"issue":"2","key":"10.1016\/j.ctarc.2023.100784_bib0054","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejon.2009.09.005","article-title":"The effect of symptom clusters on functional status and quality of life in women with breast cancer","volume":"14","author":"Dodd","year":"2010","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"Suppl 2","key":"10.1016\/j.ctarc.2023.100784_bib0055","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1111\/j.1524-4733.2007.00275.x","article-title":"Patient-reported outcomes to support medical product labeling claims: FDA perspective","volume":"10","author":"Patrick","year":"2007","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.ctarc.2023.100784_bib0056","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1200\/JCO.1997.15.3.974","article-title":"Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument","volume":"15","author":"Brady","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2023.100784_bib0057","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s11136-016-1284-8","article-title":"Assessing health-related quality of life in patients with breast cancer: a systematic and standardized comparison of available instruments using the EMPRO tool","volume":"25","author":"Maratia","year":"2016","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ctarc.2023.100784_bib0058","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7525-10-14","article-title":"A systematic review of quality of life instruments in long-term breast cancer survivors","volume":"10","author":"Chopra","year":"2012","journal-title":"Health Qual. Life Outcome."},{"issue":"8","key":"10.1016\/j.ctarc.2023.100784_bib0059","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.7314\/APJCP.2014.15.8.3533","article-title":"Health-related quality of life in women with breast cancer: a literature-based review of psychometric properties of breast cancer-specific measures","volume":"15","author":"Niu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"9","key":"10.1016\/j.ctarc.2023.100784_bib0060","doi-asserted-by":"crossref","first-page":"900","DOI":"10.6004\/jnccn.2023.0046","article-title":"NCCN guidelines insights: breast cancer screening and diagnosis version 1.2023","volume":"21","author":"Bevers","year":"2023","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ctarc.2023.100784_bib0061","series-title":"Qualitative Inquiry: The Path of Sciencing","first-page":"57","article-title":"The qualitative descriptive method","author":"Parse","year":"2001"},{"issue":"12","key":"10.1016\/j.ctarc.2023.100784_bib0062","first-page":"4639","article-title":"What symptoms are important to patients? Developing a symptom burden measure for women with breast cancer","volume":"27","author":"Whisenant","year":"2019","journal-title":"Support. Care Cancer"},{"issue":"12","key":"10.1016\/j.ctarc.2023.100784_bib0063","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/abm\/kaab010","article-title":"Financial anxiety is associated with cancer screening adherence in women at high risk of breast cancer","volume":"55","author":"Jones","year":"2021","journal-title":"Ann. Behav. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2023.100784_bib0064","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1478951509990654","article-title":"The special case of complicated grief in women at high risk for breast cancer","volume":"8","author":"Wellisch","year":"2010","journal-title":"Palliat Support Care"},{"issue":"11","key":"10.1016\/j.ctarc.2023.100784_bib0065","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/pon.5211","article-title":"Risk estimation, anxiety, and breast cancer worry in women at risk for breast cancer: A single-arm trial of personalized risk communication","volume":"28","author":"Xie","year":"2019","journal-title":"Psychooncology"},{"key":"10.1016\/j.ctarc.2023.100784_bib0066","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.breast.2020.02.004","article-title":"Breast cancer risk, worry, and anxiety: Effect on patient perceptions of false-positive screening results","volume":"50","author":"Lee","year":"2020","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.ctarc.2023.100784_bib0067","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1207\/S15324796ABM2304_9","article-title":"Anxiety and compliance among women at high risk for breast cancer","volume":"23","author":"Lindberg","year":"2001","journal-title":"Ann. Behav. Med."},{"issue":"2","key":"10.1016\/j.ctarc.2023.100784_bib0068","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10897-010-9336-7","article-title":"Genetic risk, perceived risk, and cancer worry in daughters of breast cancer patients","volume":"20","author":"Quillin","year":"2011","journal-title":"J. Genet. Couns."},{"issue":"1","key":"10.1016\/j.ctarc.2023.100784_bib0069","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10689-018-0082-6","article-title":"Reminders of cancer risk and pain catastrophizing: relationships with cancer worry and perceived risk in women with a first-degree relative with breast cancer","volume":"18","author":"Whitney","year":"2019","journal-title":"Fam. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2023.100784_bib0070","first-page":"1473","article-title":"The Continuous Shadow of My Mother's Breast Cancer\": exploring the voice of daughters","volume":"30","author":"Fang","year":"2022","journal-title":"Support. Care Cancer"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294223001065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294223001065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:57:46Z","timestamp":1762628266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294223001065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":70,"alternative-id":["S2468294223001065"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2023.100784","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The symptom burden of women with a known risk of breast cancer receiving risk reducing medication","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2023.100784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100784"}}